In addition, basic research proposed that chemerin also ameliorated liver steatosis, lobular and portal inflammation in NASH mice by promoting autophagy and alleviating oxidative stress through JAK2/STAT3 phosphorylation (55). Here, JAK2 is linked to fatty liver disease.